Patients without gallbladders who initiate weight loss injection therapy require individualized assessment and monitoring, though the fundamental approach mirrors that for patients with intact gallbladders
The joint advisory from four leading nutrition and obesity organizations recommends multivitamin supplementation for people on GLP-1 medications
doi:10.1371/journal.pone.0103982 Chiang KC, Sun CC, Chen MH, Huang CY, Hsu JT, Yeh TS, Chen LW, Kuo SF, Juang HH, Takano M et al (2016) MART-10, the new brand of 1alpha,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro
[DOI] [PMC free article] [PubMed] [Google Scholar] [102].Rubino D, Abrahamsson N, Davies M, et al
The Medicare Bridge program is a temporary demonstration project running from July of this year through December of 2027 that provides people over 65 and certain disabled individuals access to select weight loss medications, including Zepbound (tirzepatide), Foundayo (orforglipron) and Wegovy (semaglutide)